According to the National Health Insurance Statistical Yearbook published by the National Health Insurance Corporation in 2021, the total number of people who received treatment for chronic diseases in 12 The total number of patients exceeded 1.5 million. As the number exceeded 1.5 million for the first time, the importance of chronic disease management and prevention is becoming more important due to rapid aging.

Tyroscope is the world's first and only company developing a specialized digital monitoring solution for the thyroid. We met with Jaemin Park, CEO of Tyroscope, which utilizes the close relationship between thyroid hormones and heart rate to enable appropriate management and rapid response, and had a detailed discussion. span>

Please introduce your company

Tyroscope is the world's first company to develop a digital monitoring solution for hyperthyroidism and hypothyroidism, which are thyroid dysfunctions among thyroid diseases, and ophthalmopathy, a thyroid complication. /span>. Thyroid disease is a chronic disease that many patients suffer from not only in Korea but also around the world. To solve this problem, we developed the first digital monitoring of thyroid disease and are leading the field of digital monitoring of thyroid disease in the global market..

The only Asian company to be ranked in the top tier at Europe's largest startup fair 'South Summit' and the U.S. The thyroid society has recognized its technological prowess with three papers related to key technologies being selected one after another. The product's technology is trusted because it is being developed through clinical research with Seoul National University Bundang Hospital, and it holds many patents related to technology at home and abroad..

Because thyroid disease is a chronic disease, frequent follow-up and observation are important management methods.Because thyroid disease is a chronic disease, consistent follow-up is important , The tyroscope makes this possible in everyday life. This is because we have been researching and developing technology for 44years to track changes in thyroid hormone levels by monitoring heart rate collected by wearable devices. .

Please tell us about your main business

Thyroid specialist 1, 2A private app service for primary hospitals and clinics 'Healthy Glands 'and 'Glandy', a risk monitoring app for thyroid dysfunction and thyroid ophthalmopathy. >You can introduce it with .

Healthy Sam automatically provides the results of thyroid function tests conducted in the hospital and provides thyroid medication management, one-on-one disease management by a thyroid nurse( Q&A) Provides specialized functions for thyroid diseases such as . In this way, patients feel reassured about their treatment by constantly communicating with patients even outside the hospital and helping with disease care.And it plays a big role in increasing trust in medical staff. Healthy Sam Beta 7th year 2022at Nabi Sam Union Clinic in Ulsan The service was implemented and patient satisfaction rate of 94% was achieved by 2023. It was officially introduced in May.

Glandy is an app developed through many years of clinical research. Currently, anyone can download and use it in wellness form from Google Play and App Store. We applied the technology to monitor the risk of thyroid dysfunction using resting heart rate data collected by a smart watch, and when you take a picture of your eye directly with your smartphone, AI analyzes and monitors the risk of ophthalmopathy. Thanks to this, the disease can be managed safely and the risk can be predicted even if the visit cycle is longer. Glandy is currently preparing for medical device approval at home and abroad and is preparing to allow doctors to prescribe it to patients as a medical device in the future.

Do you have any future goals or directions

Worldwide, the technology to monitor thyroid disease with a wearable device is attracting attention because it was announced for the first time, It is important to prove whether treatment effectiveness is actually improved. I think it is our company's task. Tyroscope's goal is to advance into the world by proving that the quality of life of thyroid patients is improved through data.

Through global expansion, we want to improve the completeness of this business to the point that other companies will consider benchmarking tyroscopes To that end, we will successfully complete the review of the current domestic clinical trial plan and complete approval within next year without a hitch. In the future, we plan to expand our domestic partner hospital network and actively discover overseas partners..

Lastly, Thyroid hormone disease can occur in any modern person. As chronic diseases account for the largest proportion regardless of age and gender, we want to be remembered as a company that makes people's lives comfortable through solutions.